Loading…
Stereoselective synthesis of (R)-phenylephrine using recombinant Escherichia coli cells expressing a novel short-chain dehydrogenase/reductase gene from Serratia marcescens BCRC 10948
•A short-chain dehydrogenase/reductase (SM_SDR) from Serratia marcescens.•SM_SDR prefers NADPH as cofactor.•E. coli BL21 (DE3) expressing SM_SDR can produce (R)-PE from HPMAE.•Fructose is the most effective carbon source for biocatalysis. (R)-Phenylephrine [(R)-PE] is an α1-adrenergic receptor agoni...
Saved in:
Published in: | Journal of biotechnology 2014-01, Vol.170, p.6-9 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •A short-chain dehydrogenase/reductase (SM_SDR) from Serratia marcescens.•SM_SDR prefers NADPH as cofactor.•E. coli BL21 (DE3) expressing SM_SDR can produce (R)-PE from HPMAE.•Fructose is the most effective carbon source for biocatalysis.
(R)-Phenylephrine [(R)-PE] is an α1-adrenergic receptor agonist and is widely used as a nasal decongestant to treat the common cold without the side effects of other ephedrine adrenergic drugs. We identified a short-chain dehydrogenase/reductase (SM_SDR) from Serratia marcescens BCRC 10948 that was able to convert 1-(3-hydroxyphenyl)-2-(methylamino) ethanone (HPMAE) into (R)-PE. The SM_SDR used NADPH and NADH as cofactors with specific activities of 17.35±0.71 and 5.57±0.07mU/mg protein, respectively, at 30°C and pH 7.0, thereby indicating that this enzyme could be categorized as an NADPH-preferring short-chain dehydrogenase/reductase. Escherichia coli strain BL21 (DE3) expressing SM_SDR could convert HPMAE into (R)-PE with more than 99% enantiomeric excess. The productivity and conversion yield were 0.57mmolPE/lh and 51.06%, respectively, using 10mM HPMAE. Fructose was the most effective carbon source for the conversion of HPMAE to (R)-PE. |
---|---|
ISSN: | 0168-1656 1873-4863 |
DOI: | 10.1016/j.jbiotec.2013.11.011 |